Skip to main content
. 2022 Nov 14;13:1033327. doi: 10.3389/fneur.2022.1033327

Figure 1.

Figure 1

Timeline of the case and ELISA results of antibodies against ganglioside complexes. (A) The patient started inhaling N2O occasionally 2 years ago, felt numbness and weakness 2 months ago, significantly improved after receiving the treatment of IVIG, and almost recovered 6 months after the admission. (B) ELISA tests indicated the anti-GM1 IgM antibodies were positive in both CSF and serum while anti-GM1 IgG antibodies were negative. IVIG, intravenous immunoglobulin; CSF, cerebrospinal fluid.